March 22 (Reuters) - Knight Therapeutics Inc GUD.TO
* Says U.S. Commercialization partner, profounda inc has
launched Impavido (miltefosine) in united states
Source text for Eikon: ID:nMKW3VdDGa
Further company coverage: GUD.TO
March 22 (Reuters) - Knight Therapeutics Inc GUD.TO
* Says U.S. Commercialization partner, profounda inc has
launched Impavido (miltefosine) in united states
Source text for Eikon: ID:nMKW3VdDGa
Further company coverage: GUD.TO